ID   BrCa-MZ-01
AC   CVCL_5495
SY   BR-CA-MZ-01; Breast Carcinoma-MainZ-01
DR   Wikidata; Q54798203
RX   PubMed=9663605;
RX   PubMed=12800145;
CC   Doubling time: 36 hours (PubMed=9663605).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
RX   PubMed=9663605; DOI=10.1002/(SICI)1097-0215(19980729)77:3<415::AID-IJC18>3.0.CO;2-6;
RA   Mobus, Volker Jochen
RA   Moll, Roland
RA   Gerharz, Claus-Dieter
RA   Kieback, Dirk Gunter
RA   Merk, Oliver
RA   Runnebaum, Ingo Bernard
RA   Linner, S.
RA   Dreher, Liane
RA   Grill, Hans-Jorg
RA   Kreienberg, Rolf
RT   "Differential characteristics of two new tumorigenic cell lines of
RT   human breast carcinoma origin.";
RL   Int. J. Cancer 77:415-423(1998).
//
RX   PubMed=12800145; DOI=10.1002/gcc.10218;
RA   Adelaide, Jose
RA   Huang, Huai-En
RA   Murati, Anne
RA   Alsop, Amber E.
RA   Orsetti, Beatrice
RA   Mozziconacci, Marie-Joelle
RA   Popovici, Cornel
RA   Ginestier, Christophe
RA   Letessier, Anne
RA   Basset, Celine
RA   Courtay-Cahen, Celine
RA   Jacquemier, Jocelyne
RA   Theillet, Charles
RA   Birnbaum, Daniel
RA   Edwards, Paul A.W.
RA   Chaffanet, Max
RT   "A recurrent chromosome translocation breakpoint in breast and
RT   pancreatic cancer cell lines targets the neuregulin/NRG1 gene.";
RL   Genes Chromosomes Cancer 37:333-345(2003).
//